| Dr Sivatej Sarva, MBBS | |
|
451 Kingwood Medical Dr Ste 100, Kingwood, TX 77339-6408 | |
| (281) 318-2043 | |
| (281) 536-6306 |
| Full Name | Dr Sivatej Sarva |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 21 Years |
| Location | 451 Kingwood Medical Dr Ste 100, Kingwood, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124285697 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kingwood Medical Center | Kingwood, TX | Hospital |
| Memorial Hermann Northeast Hospital | Humble, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulmonary Critical Care And Sleep Specialists Pa | 0244373264 | 4 |
| Houston Intensivists Pllc | 8224460142 | 10 |
News Archive
New research shows dramatically rising visits to emergency departments (ED) related to alcohol, especially for women, with a 175% increase in alcohol-related visits from young people aged 25 to 29.
Seven percent of adults and 19 percent of children taking chemotherapy drugs in outpatient clinics or at home were given the wrong dose or experienced other mistakes involving their medications, according to a new study supported in part by HHS' Agency for Healthcare Research and Quality through its Centers for Education and Research on Therapeutics program.
Sanofi-aventis and its wholly-owned subsidiary, BiPar Sciences, today announced that The New England Journal of Medicine published the final phase II data for the investigational drug iniparib demonstrating significant clinical benefit in women with metastatic triple negative breast cancer when iniparib was administered in combination with chemotherapy agents gemcitabine/carboplatin.
A potential new treatment for septic shock and other inflammatory diseases has been discovered by Monash Institute researchers.
Yangon General Hospital has become the first clinical site in Myanmar to install new technology from Varian Medical Systems (NYSE: VAR) for treating cancer with radiotherapy.
› Verified 7 days ago
| Entity Name | Pulmonary Critical Care And Sleep Specialists Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033357066 PECOS PAC ID: 0244373264 Enrollment ID: O20100129000547 |
News Archive
New research shows dramatically rising visits to emergency departments (ED) related to alcohol, especially for women, with a 175% increase in alcohol-related visits from young people aged 25 to 29.
Seven percent of adults and 19 percent of children taking chemotherapy drugs in outpatient clinics or at home were given the wrong dose or experienced other mistakes involving their medications, according to a new study supported in part by HHS' Agency for Healthcare Research and Quality through its Centers for Education and Research on Therapeutics program.
Sanofi-aventis and its wholly-owned subsidiary, BiPar Sciences, today announced that The New England Journal of Medicine published the final phase II data for the investigational drug iniparib demonstrating significant clinical benefit in women with metastatic triple negative breast cancer when iniparib was administered in combination with chemotherapy agents gemcitabine/carboplatin.
A potential new treatment for septic shock and other inflammatory diseases has been discovered by Monash Institute researchers.
Yangon General Hospital has become the first clinical site in Myanmar to install new technology from Varian Medical Systems (NYSE: VAR) for treating cancer with radiotherapy.
› Verified 7 days ago
| Entity Name | Houston Intensivists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962055749 PECOS PAC ID: 8224460142 Enrollment ID: O20191114002819 |
News Archive
New research shows dramatically rising visits to emergency departments (ED) related to alcohol, especially for women, with a 175% increase in alcohol-related visits from young people aged 25 to 29.
Seven percent of adults and 19 percent of children taking chemotherapy drugs in outpatient clinics or at home were given the wrong dose or experienced other mistakes involving their medications, according to a new study supported in part by HHS' Agency for Healthcare Research and Quality through its Centers for Education and Research on Therapeutics program.
Sanofi-aventis and its wholly-owned subsidiary, BiPar Sciences, today announced that The New England Journal of Medicine published the final phase II data for the investigational drug iniparib demonstrating significant clinical benefit in women with metastatic triple negative breast cancer when iniparib was administered in combination with chemotherapy agents gemcitabine/carboplatin.
A potential new treatment for septic shock and other inflammatory diseases has been discovered by Monash Institute researchers.
Yangon General Hospital has become the first clinical site in Myanmar to install new technology from Varian Medical Systems (NYSE: VAR) for treating cancer with radiotherapy.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sivatej Sarva, MBBS 6500 Hospital Dr, Hannibal, MO 63401-6890 Ph: (573) 629-3536 | Dr Sivatej Sarva, MBBS 451 Kingwood Medical Dr Ste 100, Kingwood, TX 77339-6408 Ph: (281) 318-2043 |
News Archive
New research shows dramatically rising visits to emergency departments (ED) related to alcohol, especially for women, with a 175% increase in alcohol-related visits from young people aged 25 to 29.
Seven percent of adults and 19 percent of children taking chemotherapy drugs in outpatient clinics or at home were given the wrong dose or experienced other mistakes involving their medications, according to a new study supported in part by HHS' Agency for Healthcare Research and Quality through its Centers for Education and Research on Therapeutics program.
Sanofi-aventis and its wholly-owned subsidiary, BiPar Sciences, today announced that The New England Journal of Medicine published the final phase II data for the investigational drug iniparib demonstrating significant clinical benefit in women with metastatic triple negative breast cancer when iniparib was administered in combination with chemotherapy agents gemcitabine/carboplatin.
A potential new treatment for septic shock and other inflammatory diseases has been discovered by Monash Institute researchers.
Yangon General Hospital has become the first clinical site in Myanmar to install new technology from Varian Medical Systems (NYSE: VAR) for treating cancer with radiotherapy.
› Verified 7 days ago
Liza Jemison, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1330 Kingwood Dr, Suite 200, Kingwood, TX 77339 Phone: 281-348-7301 Fax: 281-348-2186 | |
Dr. Mohamed Wael J Khirfan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 24044 Highway 59 N, Kingwood, TX 77339 Phone: 281-674-7812 Fax: 281-310-6602 | |
Branden Carl Wilson, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 22999 Highway 59 N Ste 105, Kingwood, TX 77339 Phone: 281-348-8934 | |
Dr. Syed Arman Raza, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2627 Chestnut Ridge Dr, Suite 100, Kingwood, TX 77339 Phone: 281-358-1950 Fax: 281-358-3102 | |
Dr. Mary K Crow, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 22710 Professional Dr, Kingwood, TX 77339 Phone: 281-298-8444 Fax: 281-298-7720 | |
Mr. Alexander Tiu, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 22999 Highway 59 N, # 214, Kingwood, TX 77339 Phone: 281-359-5010 Fax: 281-359-5131 |